Synthons for oligonucleotide synthesis
AssigneeAvecia Biotechnology Inc.
InventorNanda D. Sinha
Life of this patent
Estimating the term…
Abstract
The present invention relates to phosphoramidite compounds, especially to a trivalent phosphorus multimer, a method of utilizing a trivalent phosphorus multimer to prepare an oligonucleotide, and a method of preparing a trivalent phosphorus multimer. In addition, the invention relates to a solid support that is derivatized with a trivalent phosphorus multimer and a method of preparing the same.
Claims55
A phosphoramidite compound comprising two or more nucleoside moieties linked by one or more internucleoside phosphorus atoms, wherein the internucleoside phosphorus atoms are phosphorus (III) atoms.
A phosphoramidite compound according to any preceding claim wherein the internucleoside phosphorus (III) atom comprises a phosphite triester group.
A trivalent phosphorus multimer represented by the following structural formula, or a stereoisomer thereof:
- 17
- wherein:
- each X1 is, independently, —O— or —S—;
- each X2 is, independently, —O—, —S—, or —NR—;
- each X3 is, independently, —O—, —S—, —CH2—, or —(CH2)2—;
- R1 is a protecting group;
- each R2 is, independently, —H, —F, —NHR6, —CH2R6 or —OR6;
- each R3 is, independently, —OCH2CH2CN, —SCH2CH2CN, a substituted or unsubstituted aliphatic group, —OR7, or —SR7;
- R4 and R5 are each, independently, a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic group, a substituted or unsubstituted aralkyl;
- or
- R4 and R5 taken together with the nitrogen to which they are bound form a heterocycloalkyl group or a heteroaromatic group;
- R is —H, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aromatic group, or an amine protecting group;
- R6 is —H, a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic group, a substituted or unsubstituted aralkyl, or a protecting group;
- R7 is a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic group or a substituted or unsubstituted aralkyl;
- each B is, independently, H or a protected or an unprotected nucleoside base;
- and
- n is 0 or a positive integer.
A trivalent phosphorus multimer represented by the following structural formula, or a stereoisomer thereof:
- 18
- wherein:
- R is —H or —OR6;
- R6 is —H, a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic group, a substituted or unsubstituted aralkyl, or an alcohol protecting group;
- R8 is a substituted or unsubstituted trityl;
- R10 and R11 are each, independently a substituted or unsubstituted aliphatic group;
- each B is, independently, H or a protected or an unprotected nucleoside base;
- and
- m is 0 or 1.
A method of preparing an oligonucleotide represented by the following structural formula, or a stereoisomer thereof:
- 19
- wherein:
- each X1 is, independently, —O— or —S—;
- each X2 is, independently, —O—, —S—, or —NR—;
- each X3 is, independently, —O—, —S—, —CH2—, or —(CH2)2—;
- each X4 is, independently, ═O or ═S;
- R is —H, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aromatic group, or an amine protecting group;
- each R2 is, independently, —H, —F, —NHR6, —CH2R6 or —OR6;
- R6 is —H, a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic group, a substituted or unsubstituted aralkyl, or a protecting group;
- each R3 is, independently, —OCH2CH2CN, —SCH2CH2CN, a substituted or unsubstituted aliphatic group, —OR7, or —SR7;
- R2 is a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic group or a substituted or unsubstituted aralkyl;
- R13 is an alcohol protecting group, an amine protecting group, a thiol protecting group, a group of the formula —Y2-L-Y1, a group of the formula —Y2-L-Y2—R15 or a solid support;
- R14 is —H or a protecting group;
- each B is, independently, H or a protected or an unprotected nucleoside base;
- and
- p is a positive integer;
- Y1 is an ester or a carboxylic acid group;
- Y is a single bond, —C(O)—, —C(O)NR17—, —C(O)O—, —NR17— or —O—;
- L is a substituted or unsubstituted aliphatic group or a substituted or unsubstituted aromatic group;
- and
- R17 is —H, a substituted or unsubstituted aliphatic group or a substituted or unsubstituted aromatic group, comprising the steps of:
- a) coupling a trivalent phosphorus multimer represented by the following structural formula, or a stereoisomer thereof:
- 20
- wherein:
- R1 is a protecting group;
- R4 and R5 are each, independently, a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic group, a substituted or unsubstituted aralkyl;
- or
- R4 and R taken together with the nitrogen to which they are bound form a heterocycloalkyl group or a heteroaromatic group;
- and
- n is 0 or a positive integer,
- with a 5′-deprotected nucleoside or oligonucleotide represented by the following structural formula, or a stereoisomer thereof:
- 21
- wherein:
- X5 is —OH or —SH;
- and
- q is 0 or a positive integer, to produce a first intermediate represented by the following structural formula, or a stereoisomer thereof:
- 22
- b) oxidizing or sulfurizing the trivalent phosphorus groups in first intermediate to form a second intermediate represented by the following structural formula, or a stereoisomer thereof:
- 23
- c) optionally capping X5 groups which did not react with the trivalent phosphorus multimer in step a);
- d) treating the second intermediate to remove R1 to form a 5′-deprotected oligonucleotide;
- and
- e) optionally repeating steps a)-d) one or more times, wherein the final step is step c) or step d), thereby preparing an oligonucleotide.
A method of preparing a trivalent phosphorus multimer represented by the following structural formula, or a stereoisomer thereof:
- 24
- wherein:
- each X1 is, independently, —O— or —S—;
- each X2 is, independently, —O—, —S—, or —NR—;
- each X3 is, independently, —O—, —S—, —CH2—, or —(CH2)2—;
- R1 is a protecting group;
- each R2 is, independently, —H. —F, —NHR6, —CH2R6 or —OR6;
- each R3 is, independently, —OCH2CH2CN, —SCH2CH2CN, a substituted or unsubstituted aliphatic group, —OR7, or —SR7;
- R4 and R5 are each, independently, a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic group, a substituted or unsubstituted aralkyl;
- or
- R4 and R5 taken together with the nitrogen to which they are bound form a heterocycloalkyl group or a heteroaromatic group;
- R is —H, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aromatic group, or an amine protecting group;
- R6 is —H, a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic group, a substituted or unsubstituted aralkyl, or a protecting group;
- R7 is a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic group or a substituted or unsubstituted aralkyl;
- each B is, independently, H or a protected or an unprotected nucleoside base;
- and
- n is 0 or a positive integer, comprising the steps of:
- a) protecting the 3′-substituent of a nucleoside represented by the following structural formula, or a stereoisomer thereof:
- 25
- thereby forming a first intermediate represented by the following structural formula, or a stereoisomer thereof:
- 26
- wherein R16 is a protecting group which is orthogonal to R1;
- b) treating the first intermediate to remove R1, thereby forming a 5′-deprotected nucleoside;
- c) reacting the 5′-deprotected nucleoside in the presence of a coupling catalyst with a compound represented by the following structural formula, or a stereoisomer thereof:
- 27
- thereby forming a dimer represented by the following structural formula, or a stereoisomer thereof:
- 28
- d) treating the 3′,5′-protected multimer to remove R6, thereby forming a 3′-deprotected dimer;
- e) optionally reacting in the presence of a coupling catalyst the 3′-deprotected dimer with a compound represented by the following structural formula, or a stereoisomer thereof:
- 29
- thereby forming a 3′,5′-protected trimer represented by the following structural formula, or a stereoisomer thereof:
- 30
- f) optionally repeating steps e) and f) one or more times, thereby forming a 3′,5′-protected multimer;
- g) treating the 3′,5′-protected multimer to remove R16, thereby forming a 3′-deprotected multimer;
- h) reacting the 3′-deprotected multimer with a trivalent phosphorus compound represented by one of the following structural formulas:
- 31
- wherein X6 is a halogen, thereby forming the trivalent phosphorus multimer.
A method of preparing a trivalent phosphorus multimer represented by the following structural formula, or a stereoisomer thereof:
- 32
- wherein:
- each X1 is, independently, —O— or —S—;
- each X2 is, independently, —O—, —S—, or —NR—;
- each X3 is, independently, —O—, —S—, —CH2—, or —(CH2)2—;
- R1 is a protecting group;
- each R2 is, independently, —H, —F, —NHR6, —CH2R6 or —OR6;
- each R3 is, independently, —OCH2CH2CN, —SCH2CH2CN, a substituted or unsubstituted aliphatic group, —OR7, or —SR7;
- R4 and R5 are each, independently, a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic group, a substituted or unsubstituted aralkyl;
- or
- R4 and R5 taken together with the nitrogen to which they are bound form a heterocycloalkyl group or a heteroaromatic group;
- R is —H, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aromatic group, or an amine protecting group;
- R6 is —H, a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic group, a substituted or unsubstituted aralkyl, or a protecting group;
- R7 is a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic group or a substituted or unsubstituted aralkyl;
- each B is, independently, H or a protected or an unprotected nucleoside base;
- and
- n is 0 or a positive integer, comprising the steps of:
- a) protecting the 3′-substituent of a nucleoside represented by the following structural formula, or a stereoisomer thereof:
- 33
- thereby forming a first intermediate represented by the following structural formula, or a stereoisomer thereof:
- 34
- wherein R1 is a protecting group which is orthogonal to R1;
- b) treating the first intermediate to remove R1, thereby forming a 5′-deprotected nucleoside;
- c) reacting the 5′-deprotected nucleoside with a trivalent phosphorus compound represented by one of the following structural formulas:
- 35
- wherein X6 is a halogen, thereby forming a 5′-phosphoramidite;
- d) reacting the 5′-phosphoramidite in the presence of a coupling catalyst with a compound represented by the following structural formula, or a stereoisomer thereof:
- 36
- thereby forming a 3′,5′-protected dimer represented by the following structural formula, or a stereoisomer thereof:
- 37
- e) treating the 3′,5′-protected dimer to remove R16, thereby forming a 3′-deprotected dimer;
- f) optionally reacting in the presence of a coupling catalyst the 3′-deprotected dimer with a compound represented by the following structural formula, or a stereoisomer thereof:
- 38
- thereby forming a 3′,5′-protected trimer represented by the following structural formula, or a stereoisomer thereof:
- 39
- g) optionally repeating steps e) and f) one or more times, thereby forming a 3′,5′-protected multimer;
- h) treating the 3′,5′-protected multimer to remove R16, thereby forming a 3′-deprotected multimer;
- i) reacting the 3′-deprotected multimer with a trivalent phosphorus compound represented by one of the following structural formulas:
- 40
- wherein X6 is a halogen, thereby forming the trivalent phosphorus
A trivalent phosphorus multimer derivatized solid support represented by the following structural formula, or a stereoisomer thereof:
- 41
- wherein:
- each X1 is, independently, —O— or —S—;
- each X2 is, independently, —O—, —S—, or —NR—;
- each X3 is, independently, —O—, —S—, —CH2—, or —(CH2)2—;
- R1 is a protecting group;
- each R2 is, independently, —H, —F, —NHR6, —CH2R6 or —OR6;
- each R3 is, independently, —OCH2CH2CN, —SCH2CH2CN, a substituted or unsubstituted aliphatic group, —OR7, or —SR7;
- R is —H, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aromatic group, or an amine protecting group;
- R6 is —H, a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic group, a substituted or unsubstituted aralkyl, or a protecting group;
- R7 is a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic group or a substituted or unsubstituted aralkyl;
- each B is, independently, H or a protected or an unprotected nucleoside base;
- L is a substituted or unsubstituted aliphatic group or a substituted or unsubstituted aromatic group;
- n is 0 or a positive integer;
- and
- R15 is a solid support.
A method of preparing a multimer derivatized solid support represented by the following structural formula, or a stereoisomer thereof:
- 42
- wherein:
- each X1 is, independently, —O— or —S—;
- each X is, independently, —O—, —S—, or —NR—;
- each X3 is, independently, —O—, —S—, —CH2—, or —(CH2)2—;
- R1 is a protecting group;
- each R2 is, independently, —H, —F, —NHR6, —CH2R6 or —OR6;
- each R3 is, independently, —OCH2CH2CN, —SCH2CH2CN, a substituted or unsubstituted aliphatic group, —OR7, or —SR7;
- R is —H, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aromatic group, or an amine protecting group;
- R6 is —H, a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic group, a substituted or unsubstituted aralkyl, or a protecting group;
- R7 is a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic group or a substituted or unsubstituted aralkyl;
- each B is, independently, H or a protected or an unprotected nucleoside base;
- L is a substituted or unsubstituted aliphatic group or a substituted or unsubstituted aromatic group;
- n is 0 or a positive integer;
- and
- R15 is a solid support, comprising the steps of:
- a) protecting a 3′-substituent of a nucleoside represented by the following structural formula, or a stereoisomer thereof:
- 43
- thereby forming a first intermediate represented by the following structural formula, or a stereoisomer thereof:
- 44
- wherein R16 is a protecting group which is orthogonal to R1;
- b) treating the first intermediate to remove R1, thereby forming a 5′-deprotected nucleoside;
- c) reacting the 5′-deprotected nucleoside in the presence of a coupling catalyst with a compound represented by the following structural formula, or a stereoisomer thereof:
- 45
- wherein:
- R4 and R5 are each, independently, a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic group, a substituted or unsubstituted aralkyl;
- or
- R4 and R5 taken together with the nitrogen to which they are bound form a heterocycloalkyl group or a heteroaromatic group;
- thereby forming a dimer represented by the following structural formula, or a stereoisomer thereof:
- 46
- d) treating the 3′,5′-protected dimer to remove R16, thereby forming a 3′-deprotected dimer;
- e) optionally reacting in the presence of a coupling catalyst the 3′deprotected dimer with a compound represented by the following structural formula, or a stereoisomer thereof:
- 47
- thereby forming a 3′,5′-protected trimer represented by the following structural formula, or a stereoisomer thereof:
- 48
- f) optionally repeating steps e) and f) one or more times, thereby forming a 3′,5′-protected multimer;
- g) treating the 3′,5′-protected multimer to remove R16, thereby forming a 3′-deprotected multimer;
- h) reacting the 3′-deprotected multimer in the presence of a base with a compound selected from the group consisting of:
- 49
- thereby forming a solid support loading reagent represented by the following structural formula, or a stereoisomer thereof:
- 50
- i) reacting the solid support loading reagent with a solid support functionalized with primary or secondary amine groups in the presence of a base and a substituted or unsubstituted dialiphatic carbodiimide, thereby preparing said multimer derivatized solid support.
A method of preparing a multimer derivatized solid support represented by the following structural formula, or a stereoisomer thereof:
- 51
- wherein:
- each X1 is, independently, —O— or —S—;
- each X2 is, independently, —O—, —S—, or —NR—;
- each X3 is, independently, —O—, —S—, —CH2—, or —(CH2)2—;
- R1 is a protecting group;
- each R2 is, independently, —H, —F, —NHR6, —CH2R6 or —OR6;
- each R3 is, independently, —OCH2CH2CN, —SCH2CH2CN, a substituted or unsubstituted aliphatic group, —OR7, or —SR7;
- R is —H, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aromatic group, or an amine protecting group;
- R6 is —H, a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic group, a substituted or unsubstituted aralkyl, or a protecting group;
- R7 is a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic group or a substituted or unsubstituted aralkyl;
- each B is, independently, H or a protected or an unprotected nucleoside base;
- L is a substituted or unsubstituted aliphatic group or a substituted or unsubstituted aromatic group;
- n is 0 or a positive integer;
- and
- R15 is a solid support, comprising the steps of:
- a) protecting the 3′-substituent of a nucleoside represented by the following structural formula, or a stereoisomer thereof:
- 52
- thereby forming a first intermediate represented by the following structural formula, or a stereoisomer thereof:
- 53
- wherein R16 is a protecting group which is orthogonal to R1;
- b) treating first intermediate with an acid to remove R1, thereby forming a 5′-deprotected nucleoside;
- c) reacting the 5′-deprotected nucleoside with a trivalent phosphorus compound represented by one of the following structural formulas:
- 54
- wherein:
- X6 is a halogen, thereby forming a 5′-phosphoramidite, thereby forming a 5′-phosphoramidite;
- and
- R4 and R5 are each, independently, a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic group, a substituted or unsubstituted aralkyl;
- or
- R4 and R5 taken together with the nitrogen to which they are bound form a heterocycloalkyl group or a heteroaromatic group;
- d) reacting the 5′-phosphoramidite in the presence or a coupling catalyst with a compound represented by the following structural formula, or a stereoisomer thereof:
- 55
- thereby forming a 3′,5′-protected dimer represented by the following structural formula, or a stereoisomer thereof:
- 56
- e) treating the 3′,5′-protected dimer to remove R16, thereby forming a 3′-deprotected dimer;
- f) optionally reacting in the presence of a coupling catalyst the 3′-deprotected dimer with a compound represented by the following structural formula, or a stereoisomer thereof:
- 57
- thereby forming a 3′,5′-protected trimer represented by the following structural formula, or a stereoisomer thereof:
- 58
- g) optionally repeating steps e) and f) one or more times, thereby forming a 3′,5′-protected multimer;
- h) treating the 3′,5′-protected multimer to remove R6, thereby forming a 3′-deprotected multimer;
- i) reacting the 3′-deprotected multimer in the presence of a base with a compound selected from the group consisting of:
- 59
- thereby forming a solid support loading reagent represented by the following structural formula, or a stereoisomer thereof:
- 60
- j) reacting the solid support loading reagent with a solid support functionalized with primary or secondary amine functional in the presence of a base and a substituted or unsubstituted dialiphatic carbodiimide, thereby preparing said multimer derivatized solid support.
Dependencies are inferred from the claim text.